October 2023: A Significant Shift in FAA Policy In September and October 2023, the FAA introduced major changes that streamlined medical certification protocol and expanded eligibility for certain weight loss medications, including GLP-1 receptor agonists such as: Semaglutide (Wegovy) Liraglutide (Saxenda) Tirzepatide (Zepbound, Mounjaro) Rather than issuing blanket prohibitions, the FAA established specific pathways for certification (including a fast-track), observation periods, documentation requirements and ongoing monitoring
When someone stops taking them, those signals can come back
What Factors Should You Consider When Choosing Between IV and Oral Glutathione
BPC-157 and Thymosin Beta-4 represent the peptides with the strongest mechanistic rationale for hemorrhoidal tissue repair
as of May 2026
Appetite suppression shrinks tolerable volume, so a companion product often has to deliver protein, fiber, and micronutrients in a fraction of a normal serving, which pushes formulators toward concentrated proteins, low-volume EAA blends, and stick-pack dosing rather than large shakes